Biol Psychiatry 55:434437 Szewczyk A, Wojtczak L (2002) Mitochondria as a pharmacological target
& Vir Biotechnology), 561 and imdusiran (ARB-270729, Arbutus Biopharma), 562 have entered Phase II clinical trials, demonstrating a strong ability to reduce HBsAg levels
E.WindischP.BaezS.NagelR
Lysosomal lipid hydrolysis provides substrates for lipid mediator synthesis in murine macrophages
In animal models of SARS, the passive administration of neutralizing antibodies to the virus resulted in attenuated disease 4 and, likewise, the induction of neutralizing antibodies via immunization in animal models of COVID-19 attenuated disease 2
As a typical example, TCPP-based MOFs (TCPP: tetrakis (4-carboxyphenyl) porphyrin) are recognized as prospective nanophotosensitizers, such as Fe-TCPP, Mn-TCPP, and Cu-TCPP, which could be decomposed in overproduced GSH conditions, leading to intracellular GSH elimination (Wan et al., 2019